Danish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

EGCG Improves Acne by Modulating Molecular Targets

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
Linket gemmes på udklipsholderen
StatusAfsluttet
Sponsorer
Seoul National University Hospital

Nøgleord

Abstrakt

Epigallocatechin-3-gallate (EGCG) may improve acne vulgaris
- major polyphenolic constituent in green tea
- known as potent anti-carcinogenic, anti-inflammatory, anti-proliferative, and antimicrobial activities
- lipid-lowering and antiandrogenic properties was reported
- EGCG can improve acne vulgaris via one of the above mentioned actions.

Beskrivelse

Acne vulgaris is one of the most prevalent skin disorders of sebaceous follicles, affecting more than 85% of adolescents in United States. Acne can persist throughout the adulthood, and even a mild form of acne might progress to permanent scarring on the face, chest and back, thereby causing significant physical and psychosocial morbidities. Acne is a multifactorial disease of which etiology has not been fully elucidated, although considerable progress has been made in understanding its pathogenesis during last decade. The major pathogenic features of acne include abnormal ductal keratinization, sebum overproduction, Propionibacterium acnes, and inflammation. Common acne medications such as topical retinoids, antibiotics and isotretinoin are associated with irritation and incomplete responses, increased bacterial resistance or untoward side events, respectively. Thus there is a continuing need for a novel, effective agent targeting different aspects of acne pathogenesis, with minimal side effects.

In the recent decade, epigallocatechin-3-gallate (EGCG), the major polyphenolic constituent in green tea, has attracted much interest on account of its potent anti-carcinogenic, anti-inflammatory, anti-proliferative, and antimicrobial activities. Preclinical, observational, and clinical trial data have indicated that EGCG can inhibit tumor initiation, promotion, progression, and angiogenesis. EGCG also suppresses neutrophil chemotaxis, and has been suggested to improve many diseases that have inflammatory components such as diabetes, kidney injuries, arthritis, allergies, dental caries, cardiovascular, gastrointestinal, and neurodegenerative diseases. In skin, EGCG has been investigated mainly in light of antioxidative, immunopotentiating and anticarcinogenic properties against chemicals or ultraviolet irradiation. Moreover, EGCG has lipid-lowering and antiandrogenic properties, and can downregulate peroxisome proliferator-activated receptor-γ expression. Based on these observations, it can be inferred that EGCG might be effective in the treatment of acne.

Datoer

Sidst bekræftet: 08/31/2012
Først indsendt: 07/22/2010
Anslået tilmelding indsendt: 09/12/2012
Først indsendt: 09/18/2012
Sidste opdatering indsendt: 09/12/2012
Sidste opdatering indsendt: 09/18/2012
Faktisk startdato for undersøgelsen: 06/30/2005
Anslået primær afslutningsdato: 05/31/2006
Anslået afslutningsdato for undersøgelsen: 05/31/2006

Tilstand eller sygdom

Acne Vulgaris

Intervention / behandling

Other: topical EGCG application on acne

Fase

-

Armgrupper

ArmIntervention / behandling
Active Comparator: Topical EGCG 1%
Seventeen subjects were designated to use 1% EGCG .Since baseline visits, affected areas of randomly allocated half sides were treated with 1% solution twice daily, whereas those of the opposite sides were treated with vehicle only (3% ethanol).
Experimental: topical EGCG 5%
Eighteen subjects were designated to use 5% EGCG, to evaluate a dose-response relationship. Since baseline visits, affected areas of randomly allocated half sides were treated with 5% EGCG solution twice daily, whereas those of the opposite sides were treated with vehicle only (3% ethanol).

Kriterier for støtteberettigelse

Alder berettiget til undersøgelse 15 Years Til 15 Years
Køn, der er berettiget til undersøgelseAll
Accepterer sunde frivilligeJa
Kriterier

Inclusion Criteria:

- age of at least 15 years

- clinical diagnosis of mild to moderate acne vulgaris

Exclusion Criteria:

- known pregnancy or lactation

- any medical illness that might influence the results of the study,

- a previous history of oral acne medication or surgical procedures including laser treatment within 6 month and topical medication within 4 weeks of study enrollment.

Resultat

Primære resultatforanstaltninger

1. Assessment of acne severity [8 week after baseline]

Lesion counts of non-inflammatory lesions (closed comedone, open comedone) and severity measured by Reeds revised scale

Sekundære resultatforanstaltninger

1. 2-mm punch biopsy of acne lesion on the EGCG-treated sides [8 week after baseline]

2. Standardized clinical photographs [8 week after baseline]

Deltag i vores
facebook-side

Den mest komplette database med medicinske urter understøttet af videnskab

  • Arbejder på 55 sprog
  • Urtekurer, der understøttes af videnskab
  • Urtegenkendelse ved billede
  • Interaktivt GPS-kort - tag urter på stedet (kommer snart)
  • Læs videnskabelige publikationer relateret til din søgning
  • Søg medicinske urter efter deres virkninger
  • Organiser dine interesser og hold dig opdateret med nyhedsundersøgelser, kliniske forsøg og patenter

Skriv et symptom eller en sygdom, og læs om urter, der kan hjælpe, skriv en urt og se sygdomme og symptomer, den bruges mod.
* Al information er baseret på offentliggjort videnskabelig forskning

Google Play badgeApp Store badge